Trial Profile
A Phase 3 Open Label Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2020
Price :
$35
*
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Adverse reactions; Registrational
- Sponsors Aclaris Therapeutics
- 16 Nov 2020 Status changed from active, no longer recruiting to completed.
- 07 Nov 2019 According to an Aclaris Therapeutics media release, the company expects to complete the study n the first half of 2020.
- 08 May 2019 According to an Aclaris Therapeutics media release, NDA submission is anticipated in the first half of 2020.